Back to top
more

HOOKIPA Pharma Inc. (HOOK)

(Delayed Data from NSDQ)

$7.83 USD

7.83
36,113

-0.12 (-1.51%)

Updated Apr 8, 2020 04:00 PM ET

After-Market: $7.80 -0.03 (-0.38%) 6:45 PM ET

Add to portfolio

2-Buy   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.13%
17.51%
9.18%
4.92%
1.66%
10.45%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

D Value | D Growth | C Momentum | D VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for HOOK

 

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for HOOKIPA Pharma Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Assets          
Cash & Equivalents 113 49 0 NA NA
Receivables 10 7 0 NA NA
Notes Receivable 0 0 0 NA NA
Inventories 0 0 0 NA NA
Other Current Assets 5 6 0 NA NA
Total Current Assets 128 62 0 NA NA
Net Property & Equipment 5 4 0 NA NA
Investments & Advances 0 0 0 NA NA
Other Non-Current Assets 0 0 0 NA NA
Deferred Charges 0 0 0 NA NA
Intangibles 0 0 0 NA NA
Deposits & Other Assets 11 2 0 NA NA
Total Assets 144 68 0 NA NA
Liabilities & Shareholders Equity 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Notes Payable 0 0 0 NA NA
Accounts Payable 1 4 0 NA NA
Current Portion Long-Term Debt 2 0 0 NA NA
Current Portion Capital Leases 0 0 0 NA NA
Accrued Expenses 8 4 0 NA NA
Income Taxes Payable 0 0 0 NA NA
Other Current Liabilities 4 7 0 NA NA
Total Current Liabilities 15 15 0 NA NA
Mortgages 0 0 0 NA NA
Deferred Taxes/Income 0 2 0 NA NA
Convertible Debt 0 0 0 NA NA
Long-Term Debt 9 4 0 NA NA
Non-Current Capital Leases 0 0 0 NA NA
Other Non-Current Liabilities 2 3 0 NA NA
Minority Interest (Liabilities) 0 0 0 NA NA
Total Liabilities 26 24 0 NA NA
Shareholders Equity 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Preferred Stock 0 105 0 NA NA
Common Stock (Par) 0 0 0 NA NA
Capital Surplus 226 3 0 NA NA
Retained Earnings -103 -60 0 NA NA
Other Equity -5 -4 0 NA NA
Treasury Stock 0 0 0 NA NA
Total Shareholder's Equity 118 44 0 NA NA
Total Liabilities & Shareholder's Equity 144 68 0 NA NA
Total Common Equity 118 -60 0 0 0
Shares Outstanding 21.50 NA NA NA NA
Book Value Per Share 5.48 0.00 0.00 0.00 0.00

Fiscal Year End for HOOKIPA Pharma Inc. falls in the month of December.

All items in Millions except Per Share data.

3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019
Assets          
Cash & Equivalents 113 124 135 71 49
Receivables 10 1 3 1 7
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 5 11 13 13 6
Total Current Assets 128 136 151 85 62
Net Property & Equipment 5 5 5 5 4
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 0 0 0 0 0
Deposits & Other Assets 11 11 12 13 2
Total Assets 144 152 168 102 68
Liabilities & Shareholders Equity 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 1 3 5 3 4
Current Portion Long-Term Debt 2 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 8 5 7 5 4
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 4 4 5 6 7
Total Current Liabilities 15 13 17 15 15
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 1 1 2
Convertible Debt 0 0 0 0 0
Long-Term Debt 9 10 11 11 4
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2 3 3 3
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 26 26 32 30 24
Shareholders Equity 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019
Preferred Stock 0 0 0 142 105
Common Stock (Par) 0 0 0 0 0
Capital Surplus 226 223 222 4 3
Retained Earnings -103 -93 -81 -69 -60
Other Equity -5 -5 -4 -4 -4
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 118 126 136 72 44
Total Liabilities & Shareholder's Equity 144 152 168 102 68
Total Common Equity 118 126 136 -70 -60
Shares Outstanding 21.50 21.50 21.50 26.00 NA
Book Value Per Share 5.48 5.85 6.33 -2.69 0.00